Hikma Pharmaceutical | HIK - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $60M in Operating Profit for its fiscal semester ending in December of 2022.


Operating Profit Change
Almirall SA ALM:SM EUR -946000 48.76M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.55B 1.46B
Bayer BAYN:GR EUR 2.97B 1.54B
Fresenius FRE:GR EUR 787M 100M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Hikma Pharmaceutical HIK:LN USD 60M 189M
Lonza Group LONN:SW CHF 896M 251M
Orion ORNBV:FH EUR 55.5M 14.8M
Recordati REC:IM EUR 173.41M 81.87M
Roche Holding ROG:VX CHF 5.93B 5.62B
UCB UCB:BB EUR 95M 395M